Administration of @ mg of tenofovir alafenamide for @ days resulted in lower tenofovir Cmax ( @ versus @ ng/mL ) and lower systemic exposures ( AUC@-t , @ versus @ ngh/mL ) compared with subjects who received tenofovir disoproxil fumarate .